KD
The startup develops therapeutic drugs targeting chronic degenerative diseases, specifically for diagnosing conditions like central retinal artery occlusion and retinitis pigmentosa. These drugs enable healthcare providers to effectively manage and treat patients suffering from intractable eye diseases.
Osaka, Japan
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops therapeutic drugs targeting chronic degenerative diseases, specifically for diagnosing conditions like central retinal artery occlusion and retinitis pigmentosa. These drugs enable healthcare providers to effectively manage and treat patients suffering from intractable eye diseases.